Axial Spondyloarthritis Drugs Market, Global Outlook and Forecast 2022-2028

Axial Spondyloarthritis Drugs Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281558 | No. of Pages: 79 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022
This report contains market size and forecasts of Axial Spondyloarthritis Drugs in global, including the following market information:
Global Axial Spondyloarthritis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Axial Spondyloarthritis Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Axial Spondyloarthritis Drugs companies in 2021 (%)
The global Axial Spondyloarthritis Drugs market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
Certolizumab Pegol Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Axial Spondyloarthritis Drugs include AstraZeneca Plc, Eli Lilly and Company, Johnson & Johnson, Novartis AG, Panacea Biotec Ltd, Sandoz International GmbH, Sun Pharma Advanced Research Company Ltd and UCB SA, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Axial Spondyloarthritis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Axial Spondyloarthritis Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Axial Spondyloarthritis Drugs Market Segment Percentages, by Type, 2021 (%)
    Certolizumab Pegol
    Etanercept Biosimilar
    Ixekizumab
    Secukinumab
    Others
Global Axial Spondyloarthritis Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Axial Spondyloarthritis Drugs Market Segment Percentages, by Application, 2021 (%)
    Clinic
    Hospital
    Home Care
Global Axial Spondyloarthritis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Axial Spondyloarthritis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Axial Spondyloarthritis Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Axial Spondyloarthritis Drugs revenues share in global market, 2021 (%)
Key companies Axial Spondyloarthritis Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Axial Spondyloarthritis Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    AstraZeneca Plc
    Eli Lilly and Company
    Johnson & Johnson
    Novartis AG
    Panacea Biotec Ltd
    Sandoz International GmbH
    Sun Pharma Advanced Research Company Ltd
    UCB SA
1 Introduction to Research & Analysis Reports
    1.1 Axial Spondyloarthritis Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Axial Spondyloarthritis Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Axial Spondyloarthritis Drugs Overall Market Size
    2.1 Global Axial Spondyloarthritis Drugs Market Size: 2021 VS 2028
    2.2 Global Axial Spondyloarthritis Drugs Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Axial Spondyloarthritis Drugs Sales: 2017-2028
3 Company Landscape
    3.1 Top Axial Spondyloarthritis Drugs Players in Global Market
    3.2 Top Global Axial Spondyloarthritis Drugs Companies Ranked by Revenue
    3.3 Global Axial Spondyloarthritis Drugs Revenue by Companies
    3.4 Global Axial Spondyloarthritis Drugs Sales by Companies
    3.5 Global Axial Spondyloarthritis Drugs Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Axial Spondyloarthritis Drugs Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Axial Spondyloarthritis Drugs Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Axial Spondyloarthritis Drugs Players in Global Market
        3.8.1 List of Global Tier 1 Axial Spondyloarthritis Drugs Companies
        3.8.2 List of Global Tier 2 and Tier 3 Axial Spondyloarthritis Drugs Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Axial Spondyloarthritis Drugs Market Size Markets, 2021 & 2028
        4.1.2 Certolizumab Pegol
        4.1.3 Etanercept Biosimilar
        4.1.4 Ixekizumab
        4.1.5 Secukinumab
        4.1.6 Others
    4.2 By Type - Global Axial Spondyloarthritis Drugs Revenue & Forecasts
        4.2.1 By Type - Global Axial Spondyloarthritis Drugs Revenue, 2017-2022
        4.2.2 By Type - Global Axial Spondyloarthritis Drugs Revenue, 2023-2028
        4.2.3 By Type - Global Axial Spondyloarthritis Drugs Revenue Market Share, 2017-2028
    4.3 By Type - Global Axial Spondyloarthritis Drugs Sales & Forecasts
        4.3.1 By Type - Global Axial Spondyloarthritis Drugs Sales, 2017-2022
        4.3.2 By Type - Global Axial Spondyloarthritis Drugs Sales, 2023-2028
        4.3.3 By Type - Global Axial Spondyloarthritis Drugs Sales Market Share, 2017-2028
    4.4 By Type - Global Axial Spondyloarthritis Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Axial Spondyloarthritis Drugs Market Size, 2021 & 2028
        5.1.2 Clinic
        5.1.3 Hospital
        5.1.4 Home Care
    5.2 By Application - Global Axial Spondyloarthritis Drugs Revenue & Forecasts
        5.2.1 By Application - Global Axial Spondyloarthritis Drugs Revenue, 2017-2022
        5.2.2 By Application - Global Axial Spondyloarthritis Drugs Revenue, 2023-2028
        5.2.3 By Application - Global Axial Spondyloarthritis Drugs Revenue Market Share, 2017-2028
    5.3 By Application - Global Axial Spondyloarthritis Drugs Sales & Forecasts
        5.3.1 By Application - Global Axial Spondyloarthritis Drugs Sales, 2017-2022
        5.3.2 By Application - Global Axial Spondyloarthritis Drugs Sales, 2023-2028
        5.3.3 By Application - Global Axial Spondyloarthritis Drugs Sales Market Share, 2017-2028
    5.4 By Application - Global Axial Spondyloarthritis Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Axial Spondyloarthritis Drugs Market Size, 2021 & 2028
    6.2 By Region - Global Axial Spondyloarthritis Drugs Revenue & Forecasts
        6.2.1 By Region - Global Axial Spondyloarthritis Drugs Revenue, 2017-2022
        6.2.2 By Region - Global Axial Spondyloarthritis Drugs Revenue, 2023-2028
        6.2.3 By Region - Global Axial Spondyloarthritis Drugs Revenue Market Share, 2017-2028
    6.3 By Region - Global Axial Spondyloarthritis Drugs Sales & Forecasts
        6.3.1 By Region - Global Axial Spondyloarthritis Drugs Sales, 2017-2022
        6.3.2 By Region - Global Axial Spondyloarthritis Drugs Sales, 2023-2028
        6.3.3 By Region - Global Axial Spondyloarthritis Drugs Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Axial Spondyloarthritis Drugs Revenue, 2017-2028
        6.4.2 By Country - North America Axial Spondyloarthritis Drugs Sales, 2017-2028
        6.4.3 US Axial Spondyloarthritis Drugs Market Size, 2017-2028
        6.4.4 Canada Axial Spondyloarthritis Drugs Market Size, 2017-2028
        6.4.5 Mexico Axial Spondyloarthritis Drugs Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Axial Spondyloarthritis Drugs Revenue, 2017-2028
        6.5.2 By Country - Europe Axial Spondyloarthritis Drugs Sales, 2017-2028
        6.5.3 Germany Axial Spondyloarthritis Drugs Market Size, 2017-2028
        6.5.4 France Axial Spondyloarthritis Drugs Market Size, 2017-2028
        6.5.5 U.K. Axial Spondyloarthritis Drugs Market Size, 2017-2028
        6.5.6 Italy Axial Spondyloarthritis Drugs Market Size, 2017-2028
        6.5.7 Russia Axial Spondyloarthritis Drugs Market Size, 2017-2028
        6.5.8 Nordic Countries Axial Spondyloarthritis Drugs Market Size, 2017-2028
        6.5.9 Benelux Axial Spondyloarthritis Drugs Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Axial Spondyloarthritis Drugs Revenue, 2017-2028
        6.6.2 By Region - Asia Axial Spondyloarthritis Drugs Sales, 2017-2028
        6.6.3 China Axial Spondyloarthritis Drugs Market Size, 2017-2028
        6.6.4 Japan Axial Spondyloarthritis Drugs Market Size, 2017-2028
        6.6.5 South Korea Axial Spondyloarthritis Drugs Market Size, 2017-2028
        6.6.6 Southeast Asia Axial Spondyloarthritis Drugs Market Size, 2017-2028
        6.6.7 India Axial Spondyloarthritis Drugs Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Axial Spondyloarthritis Drugs Revenue, 2017-2028
        6.7.2 By Country - South America Axial Spondyloarthritis Drugs Sales, 2017-2028
        6.7.3 Brazil Axial Spondyloarthritis Drugs Market Size, 2017-2028
        6.7.4 Argentina Axial Spondyloarthritis Drugs Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Axial Spondyloarthritis Drugs Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Axial Spondyloarthritis Drugs Sales, 2017-2028
        6.8.3 Turkey Axial Spondyloarthritis Drugs Market Size, 2017-2028
        6.8.4 Israel Axial Spondyloarthritis Drugs Market Size, 2017-2028
        6.8.5 Saudi Arabia Axial Spondyloarthritis Drugs Market Size, 2017-2028
        6.8.6 UAE Axial Spondyloarthritis Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 AstraZeneca Plc
        7.1.1 AstraZeneca Plc Corporate Summary
        7.1.2 AstraZeneca Plc Business Overview
        7.1.3 AstraZeneca Plc Axial Spondyloarthritis Drugs Major Product Offerings
        7.1.4 AstraZeneca Plc Axial Spondyloarthritis Drugs Sales and Revenue in Global (2017-2022)
        7.1.5 AstraZeneca Plc Key News
    7.2 Eli Lilly and Company
        7.2.1 Eli Lilly and Company Corporate Summary
        7.2.2 Eli Lilly and Company Business Overview
        7.2.3 Eli Lilly and Company Axial Spondyloarthritis Drugs Major Product Offerings
        7.2.4 Eli Lilly and Company Axial Spondyloarthritis Drugs Sales and Revenue in Global (2017-2022)
        7.2.5 Eli Lilly and Company Key News
    7.3 Johnson & Johnson
        7.3.1 Johnson & Johnson Corporate Summary
        7.3.2 Johnson & Johnson Business Overview
        7.3.3 Johnson & Johnson Axial Spondyloarthritis Drugs Major Product Offerings
        7.3.4 Johnson & Johnson Axial Spondyloarthritis Drugs Sales and Revenue in Global (2017-2022)
        7.3.5 Johnson & Johnson Key News
    7.4 Novartis AG
        7.4.1 Novartis AG Corporate Summary
        7.4.2 Novartis AG Business Overview
        7.4.3 Novartis AG Axial Spondyloarthritis Drugs Major Product Offerings
        7.4.4 Novartis AG Axial Spondyloarthritis Drugs Sales and Revenue in Global (2017-2022)
        7.4.5 Novartis AG Key News
    7.5 Panacea Biotec Ltd
        7.5.1 Panacea Biotec Ltd Corporate Summary
        7.5.2 Panacea Biotec Ltd Business Overview
        7.5.3 Panacea Biotec Ltd Axial Spondyloarthritis Drugs Major Product Offerings
        7.5.4 Panacea Biotec Ltd Axial Spondyloarthritis Drugs Sales and Revenue in Global (2017-2022)
        7.5.5 Panacea Biotec Ltd Key News
    7.6 Sandoz International GmbH
        7.6.1 Sandoz International GmbH Corporate Summary
        7.6.2 Sandoz International GmbH Business Overview
        7.6.3 Sandoz International GmbH Axial Spondyloarthritis Drugs Major Product Offerings
        7.6.4 Sandoz International GmbH Axial Spondyloarthritis Drugs Sales and Revenue in Global (2017-2022)
        7.6.5 Sandoz International GmbH Key News
    7.7 Sun Pharma Advanced Research Company Ltd
        7.7.1 Sun Pharma Advanced Research Company Ltd Corporate Summary
        7.7.2 Sun Pharma Advanced Research Company Ltd Business Overview
        7.7.3 Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Major Product Offerings
        7.7.4 Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Sales and Revenue in Global (2017-2022)
        7.7.5 Sun Pharma Advanced Research Company Ltd Key News
    7.8 UCB SA
        7.8.1 UCB SA Corporate Summary
        7.8.2 UCB SA Business Overview
        7.8.3 UCB SA Axial Spondyloarthritis Drugs Major Product Offerings
        7.8.4 UCB SA Axial Spondyloarthritis Drugs Sales and Revenue in Global (2017-2022)
        7.8.5 UCB SA Key News
8 Global Axial Spondyloarthritis Drugs Production Capacity, Analysis
    8.1 Global Axial Spondyloarthritis Drugs Production Capacity, 2017-2028
    8.2 Axial Spondyloarthritis Drugs Production Capacity of Key Manufacturers in Global Market
    8.3 Global Axial Spondyloarthritis Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Axial Spondyloarthritis Drugs Supply Chain Analysis
    10.1 Axial Spondyloarthritis Drugs Industry Value Chain
    10.2 Axial Spondyloarthritis Drugs Upstream Market
    10.3 Axial Spondyloarthritis Drugs Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Axial Spondyloarthritis Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com